Fatstim: Cause and Consequence of Neural Fatigue

Sponsor
Institut National de la Santé Et de la Recherche Médicale, France (Other)
Overall Status
Completed
CT.gov ID
NCT02721745
Collaborator
(none)
216
1
6
54.3
4

Study Details

Study Description

Brief Summary

While the scientific community understands quite well why muscles ache after prolonged exercise, the origins of mental fatigue remain totally mysterious. Existing theories remain at a psychological level, with scarce supporting evidence. Mental fatigue typically occurs after long episodes during which humans exert control on motor or cognitive processes, instead of executing routine or stimulus-driven behaviours. However, work organization (especially in risky job like airplane control or medical profession) and pathologies due to an overload of work (like burn-out) seems to be directly linked to neural fatigue. One of the consequences of neural fatigue is to alter decision-making. As an example, the choice between an immediate monetary reward and a larger but delayed monetary reward (the so called intertemporal choices) are susceptible to fatigue state of its underpinning neural network.

The investigators are proposing an exploratory study of neural fatigue, induced either in a natural way (by performing cognitive tasks for hours) or by transcranial stimulation, using three main physiological measures (Electro-encephalography to measure neural activity, indirect calorimetry to measure the metabolic cost of a cognitive effort, and pupillometry to measure cognitive effort).

This study should allow to better understand the consequences of neural fatigue on cognitive functions like decision making as well as the associated physiological variables.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Natural Fatigue
  • Device: tDCS
  • Device: TMS
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
216 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Cause and Consequence of Neural Fatigue
Actual Study Start Date :
May 23, 2016
Actual Primary Completion Date :
Sep 1, 2020
Actual Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Natural Fatigue

Brain activity will be record through EEG (physiological measure),O2 consumption will be record through a metabolic monitor (physiological measure), or eye tracker according to the group.

Behavioral: Natural Fatigue
Experimental: EEG Indirect Calorimetry Pupillometry

Experimental: tDCS anodal

Brain activity will be record through EEG (physiological measure),O2 consumption will be record through a metabolic monitor (physiological measure), or eye tracker according to the group.

Device: tDCS
Experimental: EEG Indirect Calorimetry Pupillometry

Experimental: tDCS cathodal

Brain activity will be record through EEG (physiological measure),O2 consumption will be record through a metabolic monitor (physiological measure), or eye tracker according to the group.

Device: tDCS
Experimental: EEG Indirect Calorimetry Pupillometry

Experimental: tDCS sham

Brain activity will be record through EEG (physiological measure),O2 consumption will be record through a metabolic monitor (physiological measure), or eye tracker according to the group.

Device: tDCS
Experimental: EEG Indirect Calorimetry Pupillometry

Experimental: inhibitory TMS

Brain activity will be record through EEG (physiological measure),O2 consumption will be record through a metabolic monitor (physiological measure), or eye tracker according to the group.

Device: TMS
Experimental: EEG Indirect Calorimetry Pupillometry

Experimental: Sham TMS

Brain activity will be record through EEG (physiological measure),O2 consumption will be record through a metabolic monitor (physiological measure), or eye tracker according to the group.

Device: TMS
Experimental: EEG Indirect Calorimetry Pupillometry

Outcome Measures

Primary Outcome Measures

  1. Proportion of chosen immediate reward in intertemporal questions between an immediate reward smaller than a delayed reward. [Day 0]

    Several questions between two options (an immediate reward and and a larger delayed reward) will be asked to the participants through a computer. The measure of impulsivity corresponds to the proportion of immediate reward that wil be chosen through the keyboard (left or right arrows).

  2. Physiological Measures: EEG [Day 0]

    power of electrical brain oscillation.

  3. Physiological Measures: indirect calorimetry [day 0]

    volume of O2 consumption and CO2 expulsion.

  4. Physiological Measures:pupillometry [Day 0]

    pupil dilation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 39 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Right-handed people;

  • between 20 à 39 years old;

  • able to understand the instructions and to perform the behavioral tasks of the study ;

  • informed consent to take part to the study (signature of a a consent form);

  • people being registered to social security or universal medical protection or equivalent;

Exclusion Criteria:
For each experiment:
  • neurological, psychiatric or serious illness history

  • ongoing or recently stopped (lower than three weeks) psychotropic treatment;

  • excessive psychotropic substances consumption or chronical consumption the examination day;

  • People being not able to perform the tasks (alteration of one of the cognitive functions or elementary visual disorder avoiding the identification of the experimental stimuli);

  • adult under legal protection (guardianship, or under the protection of a conservator);

  • adult people being not able to express his consent;

  • people being deprived of liberty as a consequence of an administrative or judicial decision;

  • pregnant, parturient or nursing women;

  • people taking part to another biomedical study or still being in the exclusion phase of another research;

  • hospitalized people without consent;

  • people who could not participate to the full study for any reasons.

For the experiments involving transcranial stimulation, in addition to the previous ones:
  • take of drugs known to lower the epileptogenic threshold;

  • take of barbiturate, gabapentin, topiramate, clonazepam in the 7 days before the first visit;

  • history of awareness loss;

  • people having contraindication for having a transcranial magnetic stimulation or for having an MRI examination;

  • People who does not want to be informed of any significant irregularity that could be detected during the MRI examination;

  • claustrophobic people ;

Contacts and Locations

Locations

Site City State Country Postal Code
1 ICM Paris France 75013

Sponsors and Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Institut National de la Santé Et de la Recherche Médicale, France
ClinicalTrials.gov Identifier:
NCT02721745
Other Study ID Numbers:
  • C15-59
  • 2015-A01445-44
First Posted:
Mar 29, 2016
Last Update Posted:
Aug 26, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 26, 2021